Quick answer: Apolipoprotein B, usually written apoB, is a protein found on every particle in the blood that can carry cholesterol into the artery wall. Because each of those particles carries exactly one apoB molecule, an apoB blood test counts how many of them you have, while a standard LDL cholesterol result only measures how much cholesterol they carry. In large genetic and population studies covering hundreds of thousands of people, apoB was the lipid measure that best explained the link between blood fats and heart attacks, which is why I often add it to a routine lipid panel.
Key takeaways
ApoB is a protein found on every particle that can carry cholesterol into the artery wall, so the test is a way of counting those particles.
Large genetic and cohort studies suggest particle number may track heart risk more closely than LDL cholesterol when the two disagree.
ApoB does not replace a standard lipid panel, but reading it alongside one can give a clearer picture of heart risk.
Most people know their LDL cholesterol number, and many have been told it is the one lipid result that matters most. LDL cholesterol is useful, but it measures the amount of cholesterol packed inside certain particles rather than the number of particles themselves. Over the past several years, a growing body of research has suggested that the particle count may be the more meaningful number. That count is captured by a simple blood test called apolipoprotein B, or apoB, and it is one of the functional biomarkers I find most helpful when someone wants a clearer picture of their long-term heart health.
What apoB actually measures
Cholesterol and triglycerides do not dissolve in blood, so the body moves them around inside particles called lipoproteins. The particles that can enter and become trapped in the artery wall include LDL, VLDL, and lipoprotein(a), and each one of them carries a single molecule of apoB on its surface. In a 2019 review in JAMA Cardiology, Allan Sniderman and colleagues explained that this one-to-one relationship means the apoB level in your blood equals the total number of these particles. They also noted that LDL particles far outnumber the others, with roughly nine LDL particles for every VLDL particle in people with normal triglycerides.
The reason this matters is that the amount of cholesterol inside each particle varies from person to person. Two people can have the same LDL cholesterol result while one of them has many small, cholesterol-poor particles and the other has fewer, larger ones. The review describes this as discordance, and it is the main reason apoB and LDL cholesterol can point in different directions. The authors concluded that apoB brings together the information from the standard lipid markers into a single, more accurate measure of the risk that comes from these particles. They also pointed out that fasting is not necessary to measure apoB, which makes the test convenient. The free full text is here: Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review.
What genetic evidence from over 400,000 people shows
Because LDL cholesterol, triglycerides, and apoB rise and fall together, ordinary observational studies have a hard time telling which one is doing the damage. In 2020, a team led by Tom Richardson published a study in PLOS Medicine that used a genetic method called Mendelian randomization to separate them. They studied genetic data from up to 441,016 UK Biobank participants and combined it with a large international dataset of 60,801 people with coronary heart disease and 123,504 people without it.
When each lipid was examined on its own, genetically higher LDL cholesterol, triglycerides, and apoB were all linked with a higher risk of coronary heart disease. When the researchers looked at all three together, only apoB kept a strong effect, with roughly a 1.9-fold higher odds of coronary heart disease for each standard deviation increase. The apparent effect of LDL cholesterol disappeared once apoB was taken into account, and the link with triglycerides became much weaker. The authors acknowledged that these lipid traits are so closely related that it is hard to make completely clean distinctions, but they concluded that apoB appears to be the main trait behind the relationship between blood lipids and heart disease. The free full text is here: Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease.
A large cohort study of heart attack risk
A 2022 study in JAMA Cardiology by Nicholas Marston and colleagues tested the same question in real-world outcomes. It included 389,529 UK Biobank participants who had no established atherosclerosis and were not taking cholesterol-lowering medication, followed for a median of about 11 years. It also included 40,430 people with known atherosclerosis who were taking statins and were enrolled in two large clinical trials.
In the larger group, apoB, non-HDL cholesterol, and triglycerides were each associated with heart attacks when examined separately. When they were analyzed together, only apoB remained associated, with about a 27 percent higher risk of heart attack for each standard deviation increase. The same pattern appeared in the group already taking statins. The researchers also found that once apoB was accounted for, the balance between triglyceride-rich particles and LDL particles did not add any further information about risk. Their conclusion was that heart attack risk seems to be best captured by the number of apoB-containing particles, regardless of how much cholesterol or triglyceride those particles carry. The free full text is here: Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction.
Why I like to look at apoB alongside other labs
A standard lipid panel is still a good starting point, and apoB does not replace it. What apoB adds is a direct count of the particles involved, which can be especially informative when someone’s triglycerides are high, when their blood sugar or insulin is drifting upward, or when their LDL cholesterol looks reassuring but other parts of their history do not. Those are the situations where LDL cholesterol and particle number are most likely to disagree. My articles on insulin sensitivity and blood sugar and how you age explain why metabolic health and lipid particles are so closely connected.
ApoB also pairs naturally with lipoprotein(a), since every Lp(a) particle carries apoB too. The difference is that Lp(a) is mostly inherited and is usually checked once, which I explain in my article on the inherited heart marker worth testing once, while apoB reflects diet, activity, weight, metabolic health, and genetics together and can be followed over time. I also like to see inflammation markers such as hs-CRP on the same panel. Fitness belongs in this picture as well, and my recent article on VO2 max and longevity covers one of the strongest non-lab signals of cardiovascular health. My broader guides to heart health and functional lab testing show how these pieces fit together.
A single apoB number is never interpreted in isolation. Blood pressure, family history, smoking history, blood sugar, kidney function, and age all shape what a given result means for a particular person, and any decision about medication belongs in a conversation with your own physician or cardiologist.
Wondering whether apoB belongs on your next lab panel?
A free 15-minute consultation with Dr. Kneessi. No cost, no obligation.
Questions to bring to your clinician
These questions can help you get the most out of your next visit.
How might ApoB test relate to my own health history and goals?
What would a result like my ApoB mean for me, given my health history?
Which other labs would be worth pairing with my ApoB to get a clearer picture?
When would it make sense to recheck my ApoB, and what could I work on in the meantime?
Frequently asked questions
Is apoB the same as LDL cholesterol?
No. LDL cholesterol measures how much cholesterol is carried inside LDL particles, while apoB counts the number of particles that can enter the artery wall, including LDL, VLDL, and lipoprotein(a). The two usually move together, but they can disagree when particles carry more or less cholesterol than average.
Do I need to fast before an apoB test?
According to the 2019 review by Sniderman and colleagues, fasting is not necessary to measure apoB, because the particles that appear after a meal make up only a tiny share of the total. Your lab or clinician may still ask you to fast if other tests are being drawn at the same time.
Why isn’t apoB part of every routine lipid panel?
Standard lipid panels were built around cholesterol measurements long before the particle research matured, and many offices still order the traditional panel by default. ApoB can usually be added to the same blood draw, so it is worth asking your clinician whether it makes sense for you.
Sources
- Sniderman et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiology. 2019. Free full text on PubMed Central.
- Richardson et al. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis. PLOS Medicine. 2020. Free full text on PubMed Central.
- Marston et al. Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis. JAMA Cardiology. 2022. Free full text on PubMed Central.
This article is for educational purposes only and is not medical advice. It does not replace an individual evaluation. Talk with your healthcare provider before making changes to your diet, exercise, supplements, or medications, especially if you are pregnant, nursing, or managing a health condition.
Free: The 28-Day Reset for Energy and Focus
A simple day-by-day email guide to sleep, movement, food, and daily habits that support healthy aging. It’s free, and you can unsubscribe anytime.
Get the free guide Take the supplement quiz
